Our primary objective was to determine the anti-tumor activity of cimetidine, vitamin C and their combination via targeting TAMC and its mediators (histamine, VEGF, and TNF-α) in the TME and investigating their effect on PI3K/AKT/mTOR cue in Ehrlich induced breast cancer in mice. The gene discussed is MTOR; the disease is breast cancer.